Skip to the page

Data / Drug companies / Ani Pharmaceuticals, Inc.

Ani Pharmaceuticals, Inc.: 157 products in the FDA NDC directory, labeler code 70954

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Ani Pharmaceuticals, Inc. (labeler code 70954) lists 157 products in the FDA National Drug Code Directory, covering 85 finished drugs by generic name. By type: 157 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 1, 2026.

The request: Watch Ani Pharmaceuticals, Inc. (FDA labeler code 70954): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
70954
Products in commercial distribution
157
Packages
257
Finished drugs by generic name
85
Prescription products
157
Over the counter products
0
Controlled substance products
Schedule II 1, Schedule III 1, Schedule IV 9, Schedule V 1
Flagged as original packager
146 of 146 products that carry the flag
Started marketing in the last 12 months
20
Earliest marketing start
December 5, 2015
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)14994.9%
New drug applications (NDA)85.1%

Products by type

TypeProductsShare
Prescription drugs157100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Estradiol953
Dexamethasone745
Prednisone649
Thiothixene44
Sildenafil citrate424
Alprazolam437
Fluphenazine hydrochloride429
Tadalafil354
Duloxetine336
Bisoprolol fumarate and hydrochlorothiazide312
Prazosin hydrochloride335
Hydrocortisone3171
Clorazepate dipotassium38
Digoxin333
Everolimus315
Sacubitril and valsartan329
Levocarnitine310
Prochlorperazine maleate231
Nabumetone230
Rifampin213
Bromocriptine mesylate29
Dapsone226
Prucalopride218
Omeprazole and sodium bicarbonate211
Anagrelide23
Acetazolamide237
Meloxicam254
Trihexyphenidyl hydrochloride28
Atenolol and chlorthalidone29
Pimozide22
Misoprostol215
Estazolam23
Naproxen258
Bisoprolol fumarate225
Hydroxychloroquine sulfate233
Sertraline hydrochloride255
Pirfenidone226
Dapagliflozin226
Valsartan138
Paroxetine133
Phenoxybenzamine hydrochloride15
Indomethacin136
Mirtazapine142
Macitentan115
Fosfomycin tromethamine19
Naproxen oral11
Famotidine1138
Hydroxyzine hydrochloride151
Clotrimazole topical11
Chlorzoxazone121
Alendronate sodium116
Pyrazinamide14
Lacosamide157
Terazosin111
Clomiphene citrate18
Methenamine hippurate112
Tranylcypromine13
Calcitriol123
Felbamate111
Sulfamethoxazole and trimethoprim148
Levofloxacin142
Megestrol acetate117
Pyridostigmine bromide oral11
Potassium chloride184
Methsuximide12
Carbamazepine152
Nitrofurantoin128
Selegiline hydrochloride112
Hydrochlorothiazide151
Nitazoxanide14
L-glutamine13
Ketoconazole135
Lofexidine13
Rifabutin15
Lidocaine hydrochloride1134
Acyclovir170
Methyltestosterone12
Dicyclomine hydrochloride150
Mesalamine141
Fluoxetine hydrochloride144
Pentoxifylline19
Oxybutynin chloride145
Fludrocortisone acetate115
Trimethoprim15
Tapentadol hydrochloride16

Dosage forms

Dosage formProductsShare
Tablet7145.2%
Capsule2113.4%
Solution159.6%
Tablet, film coated159.6%
Suspension106.4%
Gel53.2%
Powder, for suspension42.5%
Capsule, delayed release31.9%
Tablet, for suspension31.9%
Tablet, delayed release21.3%
Granule, for solution10.6%
For suspension10.6%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Fosfomycin Tromethamine70954-040Granule, for solutionGeneric drugs (ANDA)October 1, 2026
Macitentan70954-025Tablet, film coatedGeneric drugs (ANDA)October 1, 2026
Methenamine Hippurate70954-959TabletNew drug applications (NDA)July 27, 2026
Rifampin70954-893CapsuleGeneric drugs (ANDA)July 20, 2026
Rifampin70954-892CapsuleGeneric drugs (ANDA)July 20, 2026
Tapentadol Hydrochloride70954-801SolutionGeneric drugs (ANDA)July 13, 2026
Mirtazapine70954-830Tablet, film coatedGeneric drugs (ANDA)May 14, 2026
Mesalamine70954-301SuspensionGeneric drugs (ANDA)May 14, 2026
Dapagliflozin70954-857Tablet, film coatedGeneric drugs (ANDA)May 13, 2026
Dapagliflozin70954-856Tablet, film coatedGeneric drugs (ANDA)May 13, 2026
Calcitriol70954-831SolutionNew drug applications (NDA)May 13, 2026
Pimozide70954-854TabletGeneric drugs (ANDA)April 21, 2026
Pimozide70954-853TabletGeneric drugs (ANDA)April 21, 2026
Bromocriptine Mesylate70954-951CapsuleNew drug applications (NDA)April 6, 2026
Sertraline Hydrochloride70954-900CapsuleGeneric drugs (ANDA)January 20, 2026
Sertraline Hydrochloride70954-899CapsuleGeneric drugs (ANDA)January 20, 2026
Hydroxyzine Hydrochloride70954-912SolutionGeneric drugs (ANDA)January 15, 2026
Omeprazole and Sodium Bicarbonate70954-798Powder, for suspensionGeneric drugs (ANDA)January 15, 2026
Omeprazole and Sodium Bicarbonate70954-797Powder, for suspensionGeneric drugs (ANDA)January 15, 2026
Dexamethasone70954-872ElixirGeneric drugs (ANDA)December 1, 2025
Anagrelide70954-881CapsuleGeneric drugs (ANDA)November 6, 2025
Anagrelide70954-879CapsuleGeneric drugs (ANDA)November 6, 2025
Lofexidine70954-909TabletGeneric drugs (ANDA)October 22, 2025
Clomiphene citrate70954-825TabletGeneric drugs (ANDA)October 17, 2025
Everolimus70954-775Tablet, for suspensionGeneric drugs (ANDA)October 10, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.